Compare ARK Genomic Revolution ETF (ARKG) vs BigBearai Holdings Inc (BBAI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs BigBearai Holdings Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while BigBearai Holdings Inc trades at $3.25 (market cap $1.57B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, BigBearai Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BBAI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $8.91 |
52-Week Low | $23.09 | $3.05 |
Market Cap | — | $1.57B |
Enterprise Value | — | $1.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BigBear.ai (BBAI) trades at $3.27, down 1.51% amid bearish technical signals. The company shows persistent losses with a -226.69% net income margin despite steady $127M revenue. Recent Dutch approval for airport security technology highlights growth potential, but high SG&A expenses and negative cash flow from operations remain concerns. Technical indicators show oversold conditions with RSI at 25.86, though moving averages signal continued bearish pressure.
BBAI faces significant execution risks with negative profitability metrics, though analyst consensus leans neutral with 75% hold ratings. The stock's outlook depends on converting AI contract wins into sustainable profitability, with current valuation appearing rich given ongoing losses. Near-term catalysts include Q2 2026 earnings and defense contract execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About BigBearai Holdings Inc
BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →
